# Boston Scientific Corporation (NYSE: BSX), Quincy, MA – FDA Inspections

Source: https://www.keypedia.com/companies/boston-scientific-corporation/bf95324a-36ec-4f17-bb0f-3c56e3ec666a

> Inspection records and compliance data for Boston Scientific Corporation in Quincy, Massachusetts. 8 FDA inspections on record, last inspected September 18, 2019. Publicly traded as NYSE: BSX.

---

## Details

- Name: Boston Scientific Corporation
- FEI Number: 3001451463
- Address Line 1: 500 Commander Shea Blvd
- City: Quincy
- State: Massachusetts
- Zip Code: 02171
- Country Name: United States
- Address: 500 Commander Shea Blvd, Quincy, Massachusetts 02171, United States
- Country: United States

## Stock

- Stock ticker: BSX
- Exchange: NYSE
- Share price: $44.61
- Market cap: $64.7B
- Price as of: November 6, 2026

## Related Documents

- FDA Inspection 1127757 - Boston Scientific Corporation - 2019-09-18 — source: FDA, date: September 18, 2019
- FDA Inspection 1049800 - Boston Scientific Corporation - 2017-11-02 — source: FDA, date: November 2, 2017
- FDA Inspection 967292 - Boston Scientific Corporation - 2016-04-08 — classification: No Action Indicated (NAI), source: FDA, date: April 8, 2016
- FDA Inspection 967292 - Boston Scientific Corporation - 2016-04-08 — classification: No Action Indicated (NAI), source: FDA, date: April 8, 2016
- FDA Inspection 884908 - Boston Scientific Corporation - 2014-06-26 — classification: No Action Indicated (NAI), source: FDA, date: June 26, 2014
- FDA Inspection 884908 - Boston Scientific Corporation - 2014-06-26 — classification: No Action Indicated (NAI), source: FDA, date: June 26, 2014
- FDA Inspection 884908 - Boston Scientific Corporation - 2014-06-26 — classification: No Action Indicated (NAI), source: FDA, date: June 26, 2014
- FDA Inspection 859306 - Boston Scientific Corporation - 2013-12-11 — classification: No Action Indicated (NAI), source: FDA, date: December 11, 2013
- FDA Inspection 833224 - Boston Scientific Corporation - 2013-05-22 — classification: No Action Indicated (NAI), source: FDA, date: May 22, 2013
- [FDA Inspection 833224 - Boston Scientific Corporation - 2013-05-22](https://www.keypedia.com/records/fda_inspections/boston-scientific-corporation/b602d663-9cbd-420f-af83-c5e562a704b9) — classification: No Action Indicated (NAI), source: FDA, date: May 22, 2013

## Related Companies

- [Instrumentation Laboratory](https://www.keypedia.com/companies/instrumentation-laboratory/1a0b92a6-867f-4b86-b886-aca56014bb83)
- [UFP Technologies, Inc.](https://www.keypedia.com/companies/ufp-technologies-inc/b44f9c80-8231-4f7e-8953-7e03e2958dfe)
- [Frank Scholz X-Ray Corp.](https://www.keypedia.com/companies/frank-scholz-x-ray-corp/4de8f8e5-38a7-4063-b1bb-47534bfc9b35)
- [Pexco LLC](https://www.keypedia.com/companies/pexco-llc/33c0c618-c2a1-4c37-a3fe-3c866b454f85)
- [EndoEvolution, LLC](https://www.keypedia.com/companies/endoevolution-llc/7b6ba211-4e71-45b2-b2c4-0b95846459f3)
- [Castle, John M., MD](https://www.keypedia.com/companies/castle-john-m-md/1205053b-51b1-4990-a371-85f5a7ec79db)
- [Ives EEG Solutions, LLC](https://www.keypedia.com/companies/ives-eeg-solutions-llc/2ffbce65-c855-476e-9086-ee60b122cd70)
- [Creative Marketing Concepts](https://www.keypedia.com/companies/creative-marketing-concepts/4ecceedc-d2c7-4f99-94fb-e4f31e3040ed)
- [Peter Catalano, M.D.](https://www.keypedia.com/companies/peter-catalano-md/6cf282ec-8acf-4d8d-868e-e3f5d4bad4d4)
- [Ocean Surgical Llc](https://www.keypedia.com/companies/ocean-surgical-llc/ce636a16-c4e2-4817-9fdc-e298604188c8)